Biolink (CEO Jeong-Ho Hong) participated in the Future Innovation Tech Expo 2024 (FIX 2024), held at EXCO from October 23 to 26.
Biolink was founded by a former neurology professor at Keimyung University Dongsan Medical Center with the vision of improving healthcare through AI. The company aims to enhance clinical efficiency and address issues such as information gaps, communication barriers, and staff shortages in medical practice. Through innovative AI solutions for stroke, lung cancer, and critical care, Biolink seeks to provide faster and more accurate medical services.
Since 2023, Biolink has secured funding from 14 government-supported projects, boosting its corporate value. During this time, the company has completed GMP certification and is pursuing regulatory approval from the Korean Ministry of Food and Drug Safety for its AI medical software, which is focused on early neurological prognosis and lung cancer risk evaluation using chest CT images. After commercialization, Biolink plans to introduce its products into major university hospitals.
At FIX 2024, Biolink presented LucaCast, an AI software designed to predict the likelihood of lung cancer development within the next five years by analyzing chest CT scans before visible lesions appear. This solution aims to prevent lung cancer development and facilitate early diagnosis for timely treatment planning.
Additionally, Biolink showcased NeuroCast, which uses brain MRI images and clinical data to predict early neurological deterioration (END). NeuroCast supports decision-making when neurology specialists, such as emergency rooms or secondary hospitals, are unavailable. It allows for rapid assessment of critical neurological patients while aiding neurologists in making informed decisions.
Looking ahead, Biolink targets the U.S. market with the largest product potential. To expand its presence and distribution channels, the company plans to establish a U.S. subsidiary and promote its solutions through conferences.
FIX 2024 featured specialized exhibitions, conferences, and business programs focusing on mobility, robotics, AI, and startups. The Daegu International Future Auto & Mobility Expo 2024 at EXCO’s East Wing showcased trends in UAM, autonomous driving, batteries, components, and services. Meanwhile, the 2024 ICT Convergence Expo Korea, held in the West Wing, exhibited AI, big data, blockchain, ICT, and metaverse technologies. The 2024 Daegu Robot Expo displayed industrial robots, humanoid robots, and digital transformation solutions for the robotics industry. The “Startup Arena” was introduced to facilitate meetings between startups and experts from startup accelerators like Samsung C-Lab and Plug and Play.